Pharmaceutical composition comprising cyclic somatostatin analogues

Details for Australian Patent Application No. 2004251866 (hide)

Owner Novartis AG

Inventors Lambert, Oliver; Moser, Katrin

Agent Davies Collison Cave

Pub. Number AU-B-2004251866

PCT Pub. Number WO2005/000893

Priority 0325388.7 30.10.03 GB; 0314695.8 24.06.03 GB

Filing date 23 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 12 June 2008

International Classifications

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/655 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000893 Priority application(s): WO2005/000893

12 June 2008 Application Accepted

  Published as AU-B-2004251866

9 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251867-Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor

2004251849-Unidirectional lighting device for illuminating objects and/or for marking lanes, preferably in the airport area